Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,390 | 2 | 72.3% |
| Food and Beverage | $1,300 | 18 | 27.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $3,082 | 4 | $0 (2024) |
| TG Therapeutics, Inc. | $759.33 | 3 | $0 (2024) |
| EMD Serono, Inc. | $356.97 | 4 | $0 (2024) |
| Amgen Inc. | $159.17 | 2 | $0 (2024) |
| GENZYME CORPORATION | $125.00 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $83.55 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $56.00 | 2 | $0 (2024) |
| ANI Pharmaceuticals, Inc. | $28.18 | 1 | $0 (2024) |
| Lilly USA, LLC | $20.27 | 1 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $19.81 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,586 | 18 | Genentech USA, Inc. ($3,082) |
| 2023 | $83.55 | 1 | E.R. Squibb & Sons, L.L.C. ($83.55) |
| 2020 | $20.27 | 1 | Lilly USA, LLC ($20.27) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/16/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Immunology | ||||||
| 12/12/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $121.69 | General |
| 12/12/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Rare Disease | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $31.14 | General |
| Category: Neurology | ||||||
| 11/04/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $97.99 | General |
| 10/25/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $43.05 | General |
| 10/11/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/01/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $94.24 | General |
| 09/09/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Neurology | ||||||
| 07/11/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $134.32 | General |
| Category: Immunology | ||||||
| 07/11/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 04/13/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Consulting Fee | Cash or cash equivalent | $2,890.00 | General |
| Category: Immunology | ||||||
| 04/13/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $89.87 | General |
| Category: Immunology | ||||||
| 04/13/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $58.26 | General |
| Category: Immunology | ||||||
| 04/13/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $43.90 | General |
| Category: Immunology | ||||||
| 04/10/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: Immunology | ||||||
| 04/09/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $141.78 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/12/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $83.55 | General |
| Category: Neuroscience | ||||||
| 02/07/2020 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Neuroscience | ||||||
About Dr. Elizabeth Verter, MD
Dr. Elizabeth Verter, MD is a Neurology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2018. The National Provider Identifier (NPI) number assigned to this provider is 1841789286.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elizabeth Verter, MD has received a total of $4,690 in payments from pharmaceutical and medical device companies, with $4,586 received in 2024. These payments were reported across 20 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($3,390).
Practice Information
- Specialty Neurology
- Location Bronx, NY
- Active Since 05/01/2018
- Last Updated 09/04/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1841789286
Products in Payments
- Ocrevus (Biological) $3,082
- BRIUMVI (Drug) $759.33
- UPLIZNA (Biological) $159.17
- ZEPOSIA (Drug) $83.55
- KESIMPTA (Drug) $56.00
- PURIFIED CORTROPHIN GEL (Drug) $28.18
- EMGALITY (Drug) $20.27
- ULTOMIRIS (Biological) $19.81
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Bronx
Richard Lipton, Md, MD
Neurology — Payments: $982,914
Michael Thorpy, Md, MD
Neurology — Payments: $451,587
Rene Elkin, Md, MD
Neurology — Payments: $343,327
Jelena Pavlovic, M.d, M.D
Neurology — Payments: $130,235
Dr. Sandeep Gulati, D.o, D.O
Neurology — Payments: $124,853
Dr. Lauren Gluck, Md, MD
Neurology — Payments: $53,848